Filing Details
- Accession Number:
- 0001140361-13-031305
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-09 08:00:29
- Reporting Period:
- 2013-08-08
- Filing Date:
- 2013-08-09
- Accepted Time:
- 2013-08-09 08:00:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1069308 | Opexa Therapeutics Inc. | OPXA | Pharmaceutical Preparations (2834) | 760333165 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1573327 | Karthik Radhakrishnan | C/O Opexa Therapeutics, Inc. 2635 Technology Forest Blvd. The Woodlands TX 77381 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-08-08 | 50,000 | $1.50 | 50,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Purchased in an underwritten public offering which is expected to close on August 13, 2013.